The U.S. House passed H.R. 3747, the Accelerating Access to Dementia and Alzheimer's Provider Training (AADAPT) Act, on July 20, 2026, sending it to the Senate the next day for referral to the Committee on Health, Education, Labor, and Pensions, according to the Congressional Budget Office's cost estimate.
The bill does not create a new Medicare benefit. It funds training programs meant to help more primary care doctors recognize and manage dementia. For a Medicare family evaluating a provider right now, AADAPT is less a policy change to track than a prompt for a better conversation. It points to a specific, answerable question to bring to an appointment: does this provider take part in the kind of structured dementia training the bill is designed to expand.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resource:
- Read the official notice from House — Use this primary source to verify the official announcement.
Table of Contents
- What AADAPT Actually Does
- Who Is Behind the Bill and Where It Stands
- What the Funding Actually Pays For
- Questions to Ask a Provider Now
- What to Watch For Next
What AADAPT Actually Does
AADAPT reauthorizes the federal Project ECHO Grant Program through 2031 and widens its list of eligible specialty areas to explicitly include Alzheimer's disease and related dementias, the CBO's cost estimate shows. Project ECHO is an existing model that links primary care clinicians with academic specialists through virtual, case-based teaching sessions, rather than a one-time course or a credential a provider earns and then displays. The bill directs the Department of Health and Human Services to award one or more grants, within a year of the law taking effect, to organizations that run this kind of structured, dementia-focused ECHO training, according to the bill's text on congress.gov.
The training targets primary care providers in rural and medically underserved areas, with the goal of earlier recognition and better ongoing management of Alzheimer's and other dementias, Rep. Troy Balderson's office said. Nothing in the bill requires a provider to complete this training or obtain a new certification. It funds a voluntary education pipeline, not a licensing standard.
Who Is Behind the Bill and Where It Stands
AADAPT is led by Reps. Troy Balderson (R-OH) and Nanette Barragán (D-CA), with bipartisan co-sponsors, and Balderson's office announced the House vote the same day it happened, according to his office. The bill passed the House on July 20, 2026, and was referred to the Senate's HELP Committee the following day.
As of the bill's House passage, there has been no Senate floor vote, and the measure is not law, per its tracked status on congress.gov. That means AADAPT currently has no effect on Medicare coverage, reimbursement rates, or how a provider bills for a visit. A family should not expect any change in costs, coverage rules, or required services tied to this bill until, and unless, the Senate acts and it is signed into law.
What the Funding Actually Pays For
The CBO projects AADAPT would authorize roughly $10 million per year for the Project ECHO program across fiscal years 2027 through 2031, for a total of about $39 million in appropriated spending over 2026-2031, the CBO estimate states. That money funds free continuing-education programs for providers.
It is not a benefit a patient receives, a payment tied to a diagnosis, or a new billing code. Because of that structure, the practical effect for a Medicare family is indirect: more primary care doctors, especially in rural or underserved areas, may get access to free dementia-specific training through their own practice. Whether any individual provider takes advantage of it depends on that practice choosing to participate.
Questions to Ask a Provider Now
Since AADAPT funds voluntary training rather than mandating it, the most useful step a family can take is to ask directly about a provider's current dementia education, the CBO's bill summary notes. A provider's answer reveals more about day-to-day care quality than the bill's status in Congress. Questions worth asking at an appointment: A provider's familiarity with Project ECHO specifically, even before AADAPT becomes law, can be a useful signal: the program has existed before this bill and already serves other specialty areas.
- Does this practice participate in a Project ECHO dementia program, or an equivalent ongoing dementia-specific training series?
- How does the provider stay current on dementia diagnosis and management between formal training sessions?
- Who does the provider consult, or refer to, when a case involves a complex or uncertain diagnosis?
- Has the practice changed its screening or follow-up process for memory concerns in the past year?
What to Watch For Next
The bill's next step is Senate committee action, not a House vote. Progress, if any, will show up as committee activity within the Senate HELP Committee or, eventually, a floor vote.
Until that happens, a family's Medicare coverage and billing experience with a provider remain governed by current rules, unaffected by AADAPT's provisions. If the Senate does take it up and it becomes law, the next concrete milestone to watch is HHS issuing the required grant award within one year of enactment, since that is the step that would actually put dementia-specific Project ECHO training in front of more primary care providers.
